Embed this press release by copying the code below:
NASDAQ: SRPT Long Term Investor Notice: Investigation over Possible Wrongdoing at Sarepta Therapeutics, Inc.
NASDAQ: SRPT Long Term Investor Notice: Investigation over Possible Wrongdoing at Sarepta Therapeutics, Inc.